PURE Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $2.5M | $3.8M | $1.6M |
| FY2018 | $1.3M | $2.6M | $851.0K |
| FY2019 | $742.0K | $1.9M | $398.0K |
| FY2020 | $1.5M | $6.3M | $3.8M |
| FY2021 | $970.0K | $4.3M | $2.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $2.5M | $3.8M | $1.6M |
| FY2018 | $1.3M | $2.6M | $851.0K |
| FY2019 | $742.0K | $1.9M | $398.0K |
| FY2020 | $1.5M | $6.3M | $3.8M |
| FY2021 | $970.0K | $4.3M | $2.4M |